Scribd
Upload
106 views

AmnioMatrix - Integra

Uploaded by

Zhou WeiJie
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
106 views

AmnioMatrix - Integra

Uploaded by

Zhou WeiJie
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 2

Advanced Wound Care

TREAT
A Next Generation
Amniotic Allograft
Suspension
AmnioMatrix® is a cryopreserved suspension allograft
derived from the amniotic membrane and components
of the amniotic fluid. It is cryopreserved using the
patented CryoPrime® processing method that preserves
the structural properties of the collagen, cytokines,
growth factors, ECM and cellular materials. The liquid
based suspension is especially suited for wounds where
membrane products might not be as effective (i.e.
tunneling or deep wounds). AmnioMatrix is intended
for homologous use for the repair, reconstruction and
replacement of tissue to aid in the closing of wounds.
TREAT
AmnioMatrix®
Amniotic Allograft Suspension TREAT
AmnioMatrix is derived from tissues acquired from Ordering and Reimbursement Information
healthy mothers during planned Caesarean sections. Reference Volume HCPCS Code (per cc)
These tissues have been processed using a 25520 0.50 ml Q4139
proprietary method that helps to maintain the 25530  1.0 ml Q4139
native properties of the amniotic tissues. 25540 2.0 ml Q4139
25550 3.0 ml Q4139
Clinicians have used human amniotic tissues for
over a century as a biologic dressing in a broad Suspension Dosage/Size Information
range of therapeutic applications.2 Human
Wound Size (cm2) Volume
amniotic tissues have been shown clinically and
Under 1.0 0.50 ml
scientifically to support soft tissue repair.1
1.0–5.0 1.0 ml
1 Niknejad, H, et al. Properties of amniotic membrane for potential use in Tissue
Engineering. European Cells and Materials 2008; Vol 15: 88-99.  5.0–10.0 2.0 ml
2. Davis JW. Skin Transplantation. Johns Hopkins Med J; 1910;15:307–96.
10.0 - 20.0 4.0 ml
20.0 - 50.0 6.0 ml

Case Study: Use of Cryopreserved Human Amniotic Suspension Allograft in Challenging Wounds
Emran Sheikh, MD; Diane Maggio MSN, RN, NP-C, CRRN, CWON; Renata Weber, MD
43 year old female, status post I&D of a left breast abscess. The wound was stalled and measured 0.5 x 1.0 x 3.0 cm.

Wound was treated Wound was treated again on Day 14


Complete closure by Day 38
with AmnioMatrix® in (1.9 cm depth) and
tunnel margins Day 33 (0.4 cm depth)

Product Description Clinical Applications to Repair, Replace, and Reconstruct


• Cryopreserved liquid allograft suspension derived from the (For Homologous Use Only)
components of the amniotic membrane and amniotic fluid • Chronic and acute wounds; diabetic ulcers, venous and arterial
• Tissue recovered from live, healthy donors during a planned ulcers, and pressure ulcers
c-section • Traumatic injuries
• Burns
• Surgical wounds
Availability of these products might vary from a given country or region to another, as a result of specific local regulatory approval or clearance requirements for sale in such country or region.
nNon contractual document. The manufacturer reserves the right, without prior notice, to modify the products in order to improve their quality.
nWarning: Applicable laws restrict these products to sale by or on the order of a physician.
nConsult product labels and inserts for any indication, contraindications, hazards, warnings, precautions, and instructions for use.

For more information or to place an order, please contact:


United States, Canada, Asia, Pacific, Latin America
USA 800-654-2873 888-980-7742 fax
n

International +1 609-936-5400 +1 609-750-4259 fax


n

integralife.com

AmnioMatrix, CryoPrime, Integra and the Integra logo are registered trademarks of Integra LifeSciences Corporation or its subsidiaries in the United States and/or other countries.
©2018 Integra LifeSciences Corporation. All rights reserved. Printed in USA. 0M 0608002-2-EN

You might also like